Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

RNF123 Inhibits the Proliferation, Migration, and Invasion of Thyroid Cancer by Inhibiting KAT5-Mediated PSPC1 Histone Acetylation.

Created on 24 Aug 2026

Authors

Lin Guo, Senhe Jiang, Xuehan Wang, Yiren Feng, Gang Jin

Published in

Molecular carcinogenesis. Aug 23, 2026. Epub Aug 23, 2026.

Abstract

Thyroid cancer (THCA) is the most common endocrine malignancy worldwide, understanding the pathophysiological mechanism is vital for developing effective strategies for prevention, diagnosis, and treatment. In this study, paired tumor and adjacent noncancerous tissues were collected from THCA patients. Cell viability and proliferation were assessed using CCK-8 and EdU assays. Cell migration and invasion were evaluated by wound healing and Transwell assays. Co-immunoprecipitation was performed to examine RNF123-mediated KAT5 ubiquitination, and chromatin immunoprecipitation was used to assess KAT5 enrichment at the PSPC1 promoter. An experimental lung metastasis model was established to evaluate the effects of RNF123 overexpression on tumor growth and pulmonary metastasis. RNF123 was down-regulated in THCA tissues and cell lines, and its overexpression suppressed cell viability, proliferation, migration, and invasion. KAT5 and PSPC1 were up-regulated in THCA cells. KAT5 knockdown inhibited THCA malignant behaviors. Mechanistically, RNF123 promoted the ubiquitination and degradation of KAT5, thereby reducing KAT5-mediated histone acetylation at the PSPC1 promoter and subsequent IGF1R up-regulation. In conclusion, RNF123 inhibited THCA malignant phenotype by promoting KAT5 ubiquitination and degradation, which reduced KAT5-mediated histone acetylation at the PSPC1 promoter, thereby down-regulating PSPC1 and IGF1R expressions.

PMID:
42633698
Bibliographic data and abstract were imported from PubMed on 24 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement